Statins Raise Diabetes Risk, but CV Benefit Outweighs It

Large meta-analysis of individual participant data shows dose-dependent type 2 diabetes increase, but vascular benefit is greater.

Related Keywords

Canada ,Christina Reith ,Marie Pigeyre ,David Preiss ,Hertzelc Gerstein ,University Of Oxford ,Nuffield Department Of Population Health ,Mcmaster University ,Hamilton Health Sciences ,Cholesterol Treatment Trialist ,Lancet Diabetes ,Nuffield Department ,Population Health ,Raise Diabetes Risk ,Glucose Levels ,